Evidence map›Paper›PMID 33777719›Full record

ArticlePublic health action2021

Data quality assessment of a South African electronic registry for drug-resistant TB, 2015-2016.

R Manesen, K A Mekler, T R Molobi, A A Tyiki, M J Madlavu, K Velen, S Charalambous, Y F van der Heijden

Abstract read
In one paragraph

Article in Public health action, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

R ManesenThe Aurum Institute, Johannesburg, South Africa.
K A MeklerThe Aurum Institute, Johannesburg, South Africa.
T R MolobiThe Aurum Institute, Johannesburg, South Africa.
A A TyikiThe Aurum Institute, Johannesburg, South Africa.
M J MadlavuEastern Cape Department of Health TB programme, Eastern Cape Province, South Africa.
K VelenThe Aurum Institute, Johannesburg, South Africa.
S CharalambousThe Aurum Institute, Johannesburg, South Africa.
Y F van der HeijdenThe Aurum Institute, Johannesburg, South Africa.

Funding

Fluoroquinolone resistance in patients with multidrug-resistant tuberculosisK08AI106420 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VAN DER HEIJDEN, YURI F. · 2014 to 2018
$848k
NIAID NIH HHS K08 AI106420
6 · The paper itself

Abstract

settingAssessment of bedaquiline roll-out in South Africa requires accurate patient data in EDRWeb, a national case-based rifampicin-resistant TB (RR-TB) surveillance register.

objectiveTo ensure EDRWeb data reflect programmatic DR-TB source data, we implemented a data quality improvement initiative.

designWe conducted data quality assessments of EDRWeb data compared to paper patient folders at two South African RR-TB treatment facilities in 2015 and 2016. We assessed 80 patient records before the intervention for completeness of clinically relevant data fields, and 80 different records after the intervention for completeness and concordance. The intervention involved reviewing and updating EDRWeb along with data quality audits with direct feedback to sites.

resultsAt baseline data completeness per site was lowest for variables related to electrocardiogram (ECG) data, adverse events, and concomitant medications (completeness for these fields ranged from 0% to 80%). Post-intervention data completeness and concordance were high for all fields except those related to ECG data (ECG-related field completeness ranged from 10% to 100%).

conclusionAfter a data quality initiative, data completeness improved at each site with the exception of ECG data fields. Our findings suggest that data quality interventions may improve patient clinical registries, ultimately enabling better evidence-based decision making for TB programmes.

Indexed as

data qualitydrug-resistant tuberculosisinformation systems

Identifiers

PMID33777719
PMCPMC7987250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.